[1]
B. Stankovic et al., “Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations: Pharmacogenomics of potential drugs for COVID-19 therapy in Serbia”, J Med Biochem, vol. 39, no. 4, pp. 488–499, Sept. 2020, doi: 10.5937/jomb0-26725.